Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209–49.
Marur S, Forastiere AA. Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment. Mayo Clin Proc. 2016;91:386–96.
O’Sullivan B, Huang SH, Su J, Garden AS, Sturgis EM, Dahlstrom K, et al. Development and validation of a staging system for HPV-related oropharyngeal cancer by the International collaboration on oropharyngeal cancer network for staging (ICON-S): a multicentre cohort study. Lancet Oncol. 2016;17:440–51.
Chan KKW, Glenny A-M, Weldon JC, Furness S, Worthington HV, Wakeford H. Interventions for the treatment of oral and oropharyngeal cancers: targeted therapy and immunotherapy. Cochrane Database Syst Rev. 2015;:CD010341.
Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.
Peres LC, Mallen AR, Townsend MK, Poole EM, Trabert B, Allen NE, et al. High levels of C-Reactive protein are Associated with an increased risk of Ovarian Cancer: results from the Ovarian Cancer Cohort Consortium. Cancer Res. 2019;79:5442–51.
Article PubMed PubMed Central Google Scholar
Park S, Miller BJ. Meta-analysis of cytokine and C-reactive protein levels in high-risk psychosis. Schizophr Res. 2020;226:5–12.
Vankadara S, K P, Balmuri PK. Evaluation of serum C-Reactive protein levels in oral premalignancies and malignancies: a comparative study. J Dent (Tehran). 2018;15:358–64.
Johnson-Obaseki S, Caulley L, Corsten M, Liu G, Dimitroulakos J, Goldstein D, et al. C-reactive protein in HPV-Positive and HPV-Negative Oropharyngeal Cancer. Otolaryngol neck Surg off J Am Acad Otolaryngol Neck Surg. 2019;160:494–501.
Chawda JG, Jain SS, Patel HR, Chaduvula N, Patel K. The relationship between serum lipid levels and the risk of Oral cancer. Indian J Med Paediatr Oncol off J Indian Soc Med Paediatr Oncol. 2011;32:34–7.
Guo X-H, Wang J-Y, Gao Y, Gao M, Yu G-Y, Xiang R-L, et al. Decreased adiponectin level is associated with aggressive phenotype of tongue squamous cell carcinoma. Cancer Sci. 2013;104:206–13.
Article PubMed PubMed Central Google Scholar
Pagoni P, Dimou NL, Murphy N, Stergiakouli E. Using mendelian randomisation to assess causality in observational studies. Evid Based Ment Health. 2019;22:67–71.
Article PubMed PubMed Central Google Scholar
Burgess S, Butterworth A, Thompson SG. Mendelian randomization analysis with multiple genetic variants using summarized data. Genet Epidemiol. 2013;37:658–65.
Article PubMed PubMed Central Google Scholar
Lesseur C, Diergaarde B, Olshan AF, Wünsch-Filho V, Ness AR, Liu G, et al. Genome-wide association analyses identify new susceptibility loci for oral cavity and pharyngeal cancer. Nat Genet. 2016;48:1544–50.
Article PubMed PubMed Central Google Scholar
Davies NM, Holmes MV, Davey Smith G. Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians. BMJ. 2018;362:k601.
Article PubMed PubMed Central Google Scholar
Brion M-JA, Shakhbazov K, Visscher PM. Calculating statistical power in mendelian randomization studies. Int J Epidemiol. 2013;42:1497–501.
Ligthart S, Vaez A, Võsa U, Stathopoulou MG, de Vries PS, Prins BP, et al. Genome analyses of > 200,000 individuals identify 58 Loci for Chronic Inflammation and highlight pathways that Link inflammation and Complex disorders. Am J Hum Genet. 2018;103:691–706.
Article PubMed PubMed Central Google Scholar
Revez JA, Lin T, Qiao Z, Xue A, Holtz Y, Zhu Z, et al. Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration. Nat Commun. 2020;11:1647.
Article PubMed PubMed Central Google Scholar
Willer CJ, Schmidt EM, Sengupta S, Peloso GM, Gustafsson S, Kanoni S, et al. Discovery and refinement of loci associated with lipid levels. Nat Genet. 2013;45:1274–83.
Article PubMed PubMed Central Google Scholar
Dastani Z, Hivert M-F, Timpson N, Perry JRB, Yuan X, Scott RA, et al. Novel loci for adiponectin levels and their influence on type 2 Diabetes and metabolic traits: a multi-ethnic meta-analysis of 45,891 individuals. PLoS Genet. 2012;8:e1002607.
Article PubMed PubMed Central Google Scholar
Yaghootkar H, Zhang Y, Spracklen CN, Karaderi T, Huang LO, Bradfield J, et al. Genetic studies of leptin concentrations implicate leptin in the regulation of early adiposity. Diabetes. 2020;69:2806–18.
Article PubMed PubMed Central Google Scholar
Soranzo N, Sanna S, Wheeler E, Gieger C, Radke D, Dupuis J, et al. Common variants at 10 genomic loci influence hemoglobin A1(C) levels via glycemic and nonglycemic pathways. Diabetes. 2010;59:3229–39.
Article PubMed PubMed Central Google Scholar
Larsson SC, Carter P, Vithayathil M, Kar S, Mason AM, Burgess S. Insulin-like growth factor-1 and site-specific cancers: a mendelian randomization study. Cancer Med. 2020;9:6836–42.
Article PubMed PubMed Central Google Scholar
Wang X, Dai JY, Albanes D, Arndt V, Berndt SI, Bézieau S, et al. Mendelian randomization analysis of C-reactive protein on Colorectal cancer risk. Int J Epidemiol. 2019;48:767–80.
Robinson T, Martin RM, Yarmolinsky J. Mendelian randomisation analysis of circulating adipokines and C-reactive protein on Breast cancer risk. Int J cancer. 2020;147:1597–603.
Article PubMed PubMed Central Google Scholar
Barahona Ponce C, Scherer D, Brinster R, Boekstegers F, Marcelain K, Gárate-Calderón V, et al. Gallstones, body Mass Index, C-Reactive protein, and Gallbladder Cancer: mendelian randomization analysis of Chilean and European Genotype Data. Hepatology. 2021;73:1783–96.
Murata M. Inflammation and cancer. Environ Health Prev Med. 2018;23:50.
Article PubMed PubMed Central Google Scholar
Colotta F, Allavena P, Sica A, Garlanda C, Mantovani A. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis. 2009;30:1073–81.
Hoesel B, Schmid JA. The complexity of NF-κB signaling in inflammation and cancer. Mol Cancer. 2013;12:86.
Article PubMed PubMed Central Google Scholar
Coussens LM, Werb Z. Inflammation and cancer. Nature. 2002;420:860–7.
Article PubMed PubMed Central Google Scholar
Greten FR, Grivennikov SI. Inflammation and Cancer: triggers, mechanisms, and consequences. Immunity. 2019;51:27–41.
Article PubMed PubMed Central Google Scholar
Ghazi-Khanloosani M, Bandegi AR, Kokhaei P, Barati M, Pakdel A. CRP and LOX-1: a mechanism for increasing the tumorigenic potential of Colorectal Cancer Carcinoma Cell line. Pathol Oncol Res. 2019;25:1467–75.
Guha N, Boffetta P, Wünsch Filho V, Eluf Neto J, Shangina O, Zaridze D, et al. Oral health and risk of squamous cell carcinoma of the head and neck and esophagus: results of two multicentric case-control studies. Am J Epidemiol. 2007;166:1159–73.
Ahrens W, Pohlabeln H, Foraita R, Nelis M, Lagiou P, Lagiou A, et al. Oral health, dental care and mouthwash associated with upper aerodigestive tract cancer risk in Europe: the ARCAGE study. Oral Oncol. 2014;50:616–25.
Huang S-F, Wei F-C, Liao C-T, Wang H-M, Lin C-Y, Lo S, et al. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels. Ann Surg Oncol. 2012;19:3856–64.
Chen I-H, Liao C-T, Wang H-M, Huang J-J, Kang C-J, Huang S-F. Using SCC antigen and CRP levels as prognostic biomarkers in recurrent oral cavity squamous cell carcinoma. PLoS ONE. 2014;9:e103265.
Article PubMed PubMed Central Google Scholar
Ullah N, Ma F-R, Han J, Liu X-L, Fu Y, Liu Y-T, et al. Monomeric C-reactive protein regulates fibronectin mediated monocyte adhesion. Mol Immunol. 2020;117:122–30.
Ramos G, de O, Bernardi L, Lauxen I, Sant’Ana Filho M, Horwitz AR, Lamers ML. Fibronectin modulates cell adhesion and signaling to promote single cell Migration of highly invasive oral squamous cell carcinoma. PLoS ONE. 2016;11:e0151338.
Article PubMed PubMed Central Google Scholar
Sproston NR, Ashworth JJ. Role of C-Reactive protein at sites of inflammation and Infection. Front Immunol. 2018;9:754.
Article PubMed PubMed Central Google Scholar
Le Q-T, Fisher R, Oliner KS, Young RJ, Cao H, Kong C, et al. Prognostic and predictive significance of plasma HGF and IL-8 in a phase III trial of chemoradiation with or without tirapazamine in locoregionally advanced Head and Neck cancer. Clin cancer Res an off J Am Assoc Cancer Res. 2012;18:1798–807.
de la C
Comments (0)